Evaluation of Technology-Based Stress Reduction Techniques Prior to Vascular Access
NCT ID: NCT03220828
Last Updated: 2019-04-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
220 participants
INTERVENTIONAL
2017-08-01
2019-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
VR Usage in Non-Invasive Surgical Sub-Specialty Procedures
NCT03464955
Technology-Based Distractions During Minor Procedures
NCT03628989
Technology-Based Distractions for Minor Procedures
NCT06924814
Stress Inoculation Through Virtual Reality in the Pediatric Electrophysiology Laboratory
NCT02949401
Longitudinal Virtual Reality Use in Pediatric Surgical Procedures
NCT03832478
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this study, investigators hope to determine if technology based distractions (VR headsets) are more effective than standard care for preventing high anxiety before vascular access. As a secondary aim of the study, we seek to determine if the use of technology based distraction will result in higher parent and patient satisfaction, decreased fear, and increased compliance, while monitoring for side-effects of the intervention.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
The control group will be provided standard of care, which is no use of technologies.
No interventions assigned to this group
Intervention Group VR
Interventional arm will use technology based distractions (Virtual Reality)
Technology Based Distractions
Technology based distractions (VR headsets)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Technology Based Distractions
Technology based distractions (VR headsets)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. have comprehension of instructions in the English language
3. have parental consent
4. Pediatric patient must be undergoing non-emergent vascular access at Lucile Packard Children's Hospital in one of the 6 previously defined care areas (please see study design in Section 16).
5. Children who are normally healthy (ASA I) or have a mild systemic disease (ASA II,III)-
Exclusion Criteria
2. Children with ASA IV (severe systemic disease that is a constant threat to life) or ASA V (unstable patients not expected to survive \>24hours or without the operation)
3. H/o severe motion sickness, nausea, seizures
7 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Samuel Rodriguez
Assistant Professor,Department of Anesthesiology, Perioperative and Pain Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Samuel Rodriguez, MD
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lucile Packard Children's Hospital at Stanford
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
40232
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.